Home » Topics » Regulatory » Patents

Patents
RSS

IMMvention Therapeutix synthesizes NLRP3 inflammasome inhibitors

Nov. 17, 2021

Chinese researchers divulge GTPase KRAS mutant inhibitors

Nov. 17, 2021

Assembly Biosciences patents new compounds for HBV

Nov. 17, 2021

C4X Discovery Holdings patents NFE2L2 activators

Nov. 16, 2021

Plexxikon identifies new CD73 inhibitors

Nov. 16, 2021

Taiho Pharmaceutical presents new GTPase KRAS mutant inhibitors

Nov. 16, 2021

Roche discloses GABA-A receptor PAMs

Nov. 16, 2021

Sumitomo Dainippon Pharma patents new compounds for epilepsy

Nov. 16, 2021

Assembly Biosciences synthesizes new HBV antivirals

Nov. 15, 2021

Janssen Pharmaceutica identifies NLRP3 inflammasome inhibitors

Nov. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...